General overview of lung transplantation and review of organ allocation

Proceedings of the American Thoracic Society

Volumn 6, Issue 1, 2009, Pages 13-19

  Orens, Jonathan B ^a,c   Garrity Jr , Edward R ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lung transplantation; Organ allocation; Selection; Surgery

Indexed keywords

ACUTE GRAFT REJECTION; BACTERIAL INFECTION; BRONCHIOLITIS OBLITERANS; CHRONIC GRAFT REJECTION; COST BENEFIT ANALYSIS; GRAFT DYSFUNCTION; HEALTH CARE COST; HOSPITAL ADMISSION; HUMAN; LIFE EXPECTANCY; LUNG DISEASE; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MYCOSIS; NONHUMAN; PATIENT SELECTION; PNEUMONIA; QUALITY OF LIFE; REVIEW; SURVIVAL RATE; VIRUS INFECTION;

BRONCHIOLITIS OBLITERANS; COSTS AND COST ANALYSIS; GRAFT REJECTION; HUMANS; LUNG DISEASES; LUNG TRANSPLANTATION; PATIENT SELECTION; RISK FACTORS; TISSUE AND ORGAN PROCUREMENT; WAITING LISTS;

EID: 58549090111     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200807-072GO     Document Type: Review

References (43)

1. Demikhov VP. A new and simpler variant of heart-lung preparation of a warm-blooded animal. Bull Eksperimentalnoi Biologii i medicini 1950;24:383-390.
2. Cooper DK. Transplantation of the heart and both lungs. I. Historical review. Thorax 1969;24:383-390.
3. Hardy KJ, Webb D, Dalton M, Walker GR Jr. Lung homotransplantation in man. JAMA 1963;186:1065-1074.
4. Reitz BA, Wallwork JL, Hunt SA, Pennock JL, Billingham ME, Oyer PE, Stinson EB, Shumway NE. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med 1982;306:557-564.
5. Gohlke M, Jennings M, Heffernen M. I'll take tomorrow: the story of a courageous woman who dared to subject herself to a medical experiment - the first successful heart-lung transplant. New York: M. Evans & Co.; 1985.
6. Toronto Lung Transplant Group. Unilateral lung transplantation for pulmonary fibrosis. N Engl J Med 1986;314:1140-1145.
7. Cooper JD, Pearson FG, Patterson GA, Todd TR, Ginsberg RJ, Goldberg M, DeMajo WA. Technique of successful lung transplantation in humans. J Thorac Cardiovasc Surg 1987;93:173-181.
8. Cohen RG, Barr ML, Schenkel FA, DeMeester TR, Wells WJ, Starnes VA. Living-related donor lobectomy for bilateral lobar transplantation in patients with cystic fibrosis. Ann Thorac Surg 1994;57:1423-1427.
9. Trulock EP, Christie JD, Edwards LB, Boucek MM, Aurora P, Taylor DO, Dobbels F, Rahmel AO, Keck BM, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant 2007;26:782-795.
10. Hosenpud JD, Bennett LE, Keck BM, Edwards E, Novick RJ. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998;351:24-27.
11. United Network for Organ Sharing. 2007 OPTN/SRTR Annual report: transplant data 1997-2006. Bethesda, MD: United Network for Organ Sharing; 2007.
12. Caine N, Sharples LD, Dennis C, Higenbottam TW, Wallwork J. Measurement of health-related quality of life before and after heart-lung transplantation. J Heart Lung Transplant 1996;15:1047-1058.
13. Rutherford RM, Fisher AJ, Hilton C, Forty J, Hasan A, Gould FK, Dark JH, Corris PA. Functional status and quality of life in patients surviving 10 years after lung transplantation. Am J Transplant 2005;5:1099-1104.
14. Lanuza DM, McCabe M, Norton-Rosko M, Corliss JW, Garrity E. Symptom experiences of lung transplant recipients: comparisons across gender, pretransplantation diagnosis, and type of transplantation. Heart Lung 1999;28:429-437.
15. Singer LG, Gould MK, Tomlinson G, Theodore J. Determinants of health utility in lung and heart-lung transplant recipients. Am J Transplant 2005;5:103-109.
16. Garrity ER, Moore J, Mulligan MS, Shearon TH, Zucker MJ, Murray S. Heart and lung transplantation in the United States, 1996-2005. Am J Transplant 2007;7:1390-1403.
17. Egan TM, Murray S, Bustami RT, Shearon TH, McCullough KP, Edwards LB, Coke MA, Garrity ER, Sweet SC, Heiney DA, et al. Development of the new lung allocation system in the United States. Am J Transplant 2006;6:1212-1227.
18. Shah AS, Merlo CA, Borja M, Diener-West M, Conte JV, Orens JB. Does the UNOS lung allocation score predict early mortality in lung transplantation? Early outcomes with the new US allocation system. J Heart Lung Transplant 2007;26:s179-s180.
19. Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005;24:1454-1459.
20. Christie JD, Kotloff RM, Ahya VN, Tino G, Pochettino A, Gaughan C, et al. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 2005;171:1312-1316.
21. Arcasoy SM. Medical complications and management of lung transplant recipients. Respir Care Clin N Am 2004;10:505-529.
22. Bando K, Paradis IL, Komatsu K, Konishi H, Matsushima M, Keena RJ, Hardesty RL, Armitage JM, Griffith BP. Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation. J Thorac Cardiovasc Surg 1995;109:49-57.
23. Otulana BA, Higenbottam T, Ferrari L, Scott J, Igboaka G, Wallwork J. The use of home spirometry in detecting acute lung rejection and infection following heart-lung transplantation. Chest 1990;97:353-357.
24. Stewart S, Fishbein MC, Snell GI, Berry GJ, Boehler A, Burke MM, Glanville A, Gould FK, Magro C, Marboe CC, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007;26:1229-1242.
25. Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M, Mallory GB, Snell GI, Yousem S. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002;21:297-310.
26. Bando K, Paradis IL, Similo S, Konishi H, Komatsu K, Zullo TG, Yousem SA, Close JM, Zeevi A, Duquesnoy RJ, et al. Obliterative bronchiolitis after lung and heart-lung transplantation: an analysis of risk factors and management. J Thorac Cardiovasc Surg 1995;110:4-13.
27. Girgis RE, Tu I, Berry GJ, Reichenspurner H, Valentine VG, Conte JV, Ting A, Johnstone I, Miller J, Robbins RC, et al. Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant 1996;15:1200-1208.
28. Kroshus TJ, Kshettry VR, Savik K, John R, Hertz MI, Bolman RMI. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg 1997;114:195.
29. Husain AN, Siddiqui MT, Holmes EW, Chandrasekhar AJ, McCabe M, Radvany R, Garrity ER. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 1999;159:829-833.
30. Cooper JD, Billingham M, Egan MI, Hertz MI, Higenbottam T, Lynch T, Mauer J, Paradis I, Patterson GA, Smith C, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts: The International Society for Heart and Lung Transplantation. J Heart Lung Transplant 1993;12:713-716.
31. Heng D, Sharples LD, McNeil K, Stewart S, Wreghitt T, Wallwork J. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant 1998;17:1255-1263.
32. Estenne M, Hertz MI. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med 2002;166:440-444.
33. Hadjiliadis D, Duane DR, Steele MP, Messier RH, Lau CL, Eubanks SS, et al. Gastroesophageal reflux disease in lung transplant recipients. Clin Transplant 2003;17:363-368.
34. Davis RD Jr, Lau CL, Eubanks S, Messier RH, Hadjiliadis D, Steele MP, Palmer SM. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg 2003;125:533-542.
35. Gerhardt SG, McDyer JF, Girgis RE, Conte JV, Yang SC, Orens JB. Maintenance azithromycintherapy for bronchiolitisobliterans syndrome: results of a pilot study. Am J Respir Crit Care Med 2003;168:121-125.
36. Corris PA, Christie JD. Update in transplantation 2007. Am J Respir Crit Care Med 2008;177:1062-1067.
37. Maurer JR, Tullis DE, Grossman RF, Vellend H, Winton TL, Patterson GA. Infectious complications following isolated lung transplantation. Chest 1992;101:1056-1059.
38. Kumar D, Erdman D, Keshavjee S, Peret T, Tellier R, Hadjiliadis D, Johnson G, Ayers M, Siegal D, Humar A. Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant 2005;5:2031-2036.
39. Khalifah AP, Hachem RR, Chakinala MM, Schechtman KB, Patterson GA, Schuster DP, Mohanakumar T, Trulock EP, Walter MJ. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med 2004;170:181-187.
40. Sharp L. Strange harvest: organ transplantation, denatured bodies, and the transformed self. Berkeley, CA: University of California Press; 2006.
41. University Health Systems Consortium (accessed May 22, 2008 and July 16, 2008). Available from: http://www.uhc.org.
42. TenVergert EM, Essink-Bot ML, Geertsma A, van Enckevort PJ, de Boer WJ, van der BW. The effect of lung transplantation on health-related quality of life: a longitudinal study. Chest 1998;113:358-364.
43. Orens JB, Estenne M, Arcasoy S, Conte JV, Corris P, Egan JJ, Egan T, Keshavjee S, Knoop C, Kotloff R, et al. International guidelines for the selection of lung transplant candidates: 2006 update-a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006;25:745-755.